Previously home to Novartis, current ownership is converting ... their requirements,” Stifelman said of the Parsippany office building. Based in New Jersey, Day Pitney boasts more than 300 ...

Microsoft (MSFT) is pouring more of its AI-powered Copilot technology into its Microsoft 365 productivity products, including ...

On Tuesday Roche announced the inauguration of its new “Pharma Research and Early Development Centre” at its global ...

and therefore building its presence and capability in India makes sense to accelerate its plans. Last year Illumina recorded global revenues of USD4.4 billion. In India, it opened a new office and ...

An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early breast cancer. The FDA has greenlighted Novartis’ Kisqali, used in ...

Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But on Tuesday, the Food and Drug Administration approved ...

Milan Jaros / Bloomberg via Getty Images Novartis said its Kisqali breast cancer drug produced longer success for those with certain forms of the disease. The drug maker reported Kisqali along ...

Pharmaceutical giant Novartis is building a new manufacturing facility in Carlsbad that will help expand the production of its precision cancer treatments. The new site will focus on radioligand ...

Novartis AG’s breast cancer drug helped prevent the disease coming back a year after treatment had ended, in new data that will be closely compared with a rival product from Eli Lilly. Novartis ...

Drugmakers at the top of the list were Astellas, AstraZeneca, Daiichi Sankyo, Gilead Sciences and Novartis. The five companies accounted for 71% of the high-benefit approvals over the past four years.